Telescope Innovations to Deliver First Self-Driving Lab for Korea's Largest Biopharma Manufacturers Association

Korea's leading biopharma association selects Telescope's Self-Driving Lab to anchor the country's first AI-driven training hub

HIGHLIGHTS

• This installation for Korea's largest biopharma association represents the first Self-Driving Lab ("SDL") for drug development to be deployed in Korea
• Partnership supports Korea's transition toward automated and digital R&D
• SDL automates continuous experimental optimization using robotics, analytics, and AI
• SDLs show expanding commercial relevance across pharma, minerals, energy, agriculture, and chemicals industries.

Vancouver, British Columbia--(Newsfile Corp. - November 17, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") today announces that the Korean Pharmaceutical and Biopharmaceutical Manufacturers Association ("KPBMA") has purchased one of Telescope's Self-Driving Lab ("SDL") platforms to be installed at a brand-new R&D facility in Seoul in a matter of weeks. This groundbreaking facility aims to provide critical infrastructure to enable accelerated development of pharmaceuticals.

A Self-Driving Lab is an automated platform that uses robotics, inline analytics, and AI or machine-learning to run and optimize experiments in a continuous closed-loop workflow. Because it can operate continuously and adapt each experiment in real time, an SDL can complete and refine hundreds of experimental cycles far faster and with greater consistency than manual laboratory work. SDLs can dramatically accelerate iterative R&D, offering the potential to remove years from traditional development timelines and shorten the path from discovery to market-ready products. Telescope is recognized globally as one of the most advanced developers of Self-Driving Lab systems, with a uniquely integrated platform that enables true closed-loop, autonomous chemical experimentation.

Figure 1. A robotic element of Telescope's Self-Driving Lab.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8923/274498_89be634204169a49_001 ...

TELESCOPE SDL TO BE IMPLEMENTED AT THE FIRST AI-DRIVEN TRAINING HUB IN KOREA

KPBMA is the largest trade association of Korea's pharmaceutical and biotech industry, with 300 domestic and multinational member companies. Key elements of KPBMA's mission are to support R&D and foster innovation in pharmaceutical manufacturing. This year, KPBMA launched its first SDL initiative through its Convergence AI Institute for Drug Discovery (CAIID) to promote automation and AI-driven experimentation. Telescope's SDLs will form part of the training hub to demonstrate innovative infrastructure, provide education, and upskill researchers to fully capitalize on this new R&D method. Telescope is installing the SDL over the next few weeks, beyond which Telescope and KPBMA are building a strategic partnership for SDL deployment and adoption in Korea's pharmaceutical sector.